Related Experiment Video

Updated: Aug 6, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

New insights on inflammation in chronic kidney disease-genetic and non-genetic factors

Peter Stenvinkel1

  • 1Division of renal medicine K56, department of clinical science, Karolinska Institutet, Karolinska University Hospital at Huddinge, 14186 Stockholm, Suède. peter.stenvinkel@ki.se

Nephrologie & Therapeutique
|August 8, 2006
PubMed

Insights

Inflammation significantly contributes to cardiovascular disease (CVD) in chronic kidney disease (CKD) patients. Inflammatory biomarkers like C-reactive protein (CRP) predict mortality, with causes including dialysis and genetic factors.

Area of Science:

  • Nephrology
  • Cardiology
  • Immunology

Background:

  • Cardiovascular disease (CVD) is the leading cause of death in chronic kidney disease (CKD).
  • Traditional risk factors do not fully explain the high CVD rates in CKD.
  • Inflammation is increasingly recognized as a key contributor to CVD in CKD.

Purpose of the Study:

  • To highlight the significant role of inflammation in CVD among CKD patients.
  • To discuss the multifactorial causes of inflammation in CKD.
  • To explore the impact of genetic factors on inflammation and outcomes in CKD.

Main Methods:

  • Review of existing literature on inflammation and CVD in CKD.
  • Analysis of inflammatory biomarkers, including high-sensitivity C-reactive protein (hs-CRP).
  • Consideration of genetic factors like cytokine DNA polymorphisms.

Main Results:

  • Inflammation, linked to insulin resistance and oxidative stress, is a major driver of CVD in CKD.
  • Biomarkers such as hs-CRP independently predict mortality in CKD patients.
  • Multiple factors contribute to inflammation, including dialysis procedures and genetic predispositions.

Conclusions:

  • Inflammation is a critical, independent risk factor for cardiovascular mortality in CKD.
  • Understanding the causes of inflammation, including genetic factors, is crucial for managing CVD in CKD.
  • Targeting inflammation may improve outcomes for CKD patients with cardiovascular complications.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...